Mitochondria, oxidative damage, and inflammation in Parkinson's disease.
about
Mechanisms of rotenone-induced proteasome inhibitionExclusion of PINK1 as candidate gene for the late-onset form of Parkinson's disease in two European populations.Mitochondrial dysfunction and oxidative stress in Parkinson's diseaseEfficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization.Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductanceYounger age at onset of sporadic Parkinson's disease among subjects occupationally exposed to metals and pesticidesLoss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stressIdentification of novel proteins affected by rotenone in mitochondria of dopaminergic cellsAntioxidant potential, cytotoxic activity and total phenolic content of Alpinia pahangensis rhizomes.Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIPThe approximate entropy of the electromyographic signals of tremor correlates with the osmotic fragility of human erythrocytesNew Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.Neuroproteomics as a promising tool in Parkinson's disease research.Malate-aspartate shuttle mediates the intracellular ATP levels, antioxidation capacity and survival of differentiated PC12 cells.Nicotinamide mononucleotide improves energy activity and survival rate in an in vitro model of Parkinson's disease.Antioxidant therapy in Alzheimer's disease: theory and practice.Particulate matter neurotoxicity in culture is size-dependentLeucine-rich repeat kinase 2: a new player with a familiar theme for Parkinson's disease pathogenesis.Mitochondrial uncoupling protein-2 (UCP2) mediates leptin protection against MPP+ toxicity in neuronal cells.Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet.Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1α signaling pathway.Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.Salvage of oxidized guanine derivatives in the (2'-deoxy)ribonucleotide pool as source of mutations in DNA.Age-associated changes in oxidative stress and NAD+ metabolism in human tissue.Human adipose tissue-derived multilineage progenitor cells exposed to oxidative stress induce neurite outgrowth in PC12 cells through p38 MAPK signalingPgc-1α overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf.Eryptosis as a marker of Parkinson's diseaseDrosophila models of neurodegenerative diseases.Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease.Characterization of reduced and oxidized dopamine and 3,4-dihydrophenylacetic acid, on brain mitochondrial electron transport chain activities.Antioxidants put Parkinson flies back in the PINK.Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission.Why are there no proven therapies for genetic mitochondrial diseases?Insulin resistance impairs nigrostriatal dopamine functionHistopathological, ultrastructural, and immunohistochemical assessment of hippocampus structures of rats exposed to TCDD and high doses of tocopherol and acetylsalicylic acid.Differential expression of sirtuins in the aging rat brainGSTpi expression mediates dopaminergic neuron sensitivity in experimental parkinsonism.Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responsesPesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model
P2860
Q24633912-1FEA294E-2D3B-4565-89EB-B304822EE2A4Q25255429-6D7A65F4-5560-4BCC-B831-52A6C3E55456Q27014051-4F702B02-95BA-49A0-9720-5F8F29A16879Q27304699-5EE35733-67DD-4F01-8DF7-E9217FAC9DB6Q28392011-AF7FD2B1-862D-4D2A-88CC-99390D4A8714Q28394233-BEA888A3-B6B2-4FF0-8C19-6411A8F84EA6Q28592727-72B2B583-FD72-4019-9175-1864753CF862Q33294492-FD09E200-9DD7-4DF7-834F-724408D2C4CEQ33459393-7E7C3535-38D5-41E5-8F09-F5D3227E1C9DQ33470287-61AF178F-BC8D-4D16-BAAF-DDD86EF3E1E4Q33613058-2098BC5B-44FB-491D-87D6-061DC45C60D8Q33783000-36646CC1-1B23-4B1B-B34C-BE50A2A6D0ABQ33821316-634A474D-FA27-4BF8-A8C4-228AD1720B98Q33932637-1411DE04-5905-46E0-B94B-C6677AB084C6Q33962110-52393D11-0E9A-4CA4-9D6F-A71C6C1791D1Q34066474-64A21FFC-6B86-4A06-BCA5-46EC6695A384Q34068032-14AABCB3-87C7-487C-A456-B99A196BBE9CQ34133422-B05FE422-2A45-4C26-87F1-F1C635A403E3Q34159287-407B6317-7639-43F0-A911-BBBB3B4B0C38Q34212422-2C3EEC76-8FBD-4343-9FC5-607D69A6783EQ34320082-DF200FC4-AF5C-45C4-9E14-39749A3C66C0Q34335567-D8AD264E-567B-41EC-8DDC-34617CDC4D9FQ34348727-BDBE2CF1-C71A-4CF9-9D36-BF0ECDBF6F21Q34359729-11F70103-9780-4C78-8940-E2BFB4575362Q34369955-24543675-878A-414A-97C3-D053D847FCD5Q34473733-C3F974FF-24CB-4339-80A0-F6CE5668A2D8Q34585744-7D5CA17E-BD28-4C2B-8458-222B73AB14A2Q34610331-4302E0BC-3CE9-4D4C-A43C-581C386C0609Q35016920-70D4B7A2-306B-4056-84EC-BCF9140AD846Q35024921-BD93F710-7F2F-4043-893B-C893D4779C9BQ35037195-C2908886-B90F-410C-9CC9-6ED957B37BF2Q35149686-61410FEF-B5C2-4C50-8763-D1DE91FB8744Q35162928-5587AD4F-C44D-4E92-ADE7-AD0A2624A483Q35202338-F985CF9D-AAC6-4FC6-8571-02476B202660Q35297518-141C7118-6876-4875-B3A4-85EE0DCF2C7DQ35584969-943E6815-3785-46C0-894B-CFBAD71C8D6CQ35616756-659642DB-7D9E-4F88-A45E-8DF32D06A4FBQ35632000-991A6BD3-8ABD-422C-BB69-D5D01AC009E7Q35674485-07FB623C-8655-4E4C-BF57-E4D5B697240BQ35750160-BA2F7FF8-9EFF-4646-BD5F-63215390EE4B
P2860
Mitochondria, oxidative damage, and inflammation in Parkinson's disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Mitochondria, oxidative damage, and inflammation in Parkinson's disease.
@ast
Mitochondria, oxidative damage, and inflammation in Parkinson's disease.
@en
Mitochondria, oxidative damage, and inflammation in Parkinson's disease.
@nl
type
label
Mitochondria, oxidative damage, and inflammation in Parkinson's disease.
@ast
Mitochondria, oxidative damage, and inflammation in Parkinson's disease.
@en
Mitochondria, oxidative damage, and inflammation in Parkinson's disease.
@nl
prefLabel
Mitochondria, oxidative damage, and inflammation in Parkinson's disease.
@ast
Mitochondria, oxidative damage, and inflammation in Parkinson's disease.
@en
Mitochondria, oxidative damage, and inflammation in Parkinson's disease.
@nl
P1476
Mitochondria, oxidative damage, and inflammation in Parkinson's disease.
@en
P2093
M Flint Beal
P304
P407
P577
2003-06-01T00:00:00Z